Abstract
Background: A high number of vitamin K antagonist (VKA) users have a low proportion of time in therapeutic range (TTR) resulting in a high number of bleeding and thromboembolism events. Objective: Can the quality of anticoagulation be improved by dispensing VKAs via multidose drug dispensing (MDD). Method: A randomized controlled trial in the Netherlands. Patients who used VKAs, ≥65 years of age with a TTR <65% were eligible for inclusion. All oral drugs were dispensed via MDD. In MDD systems, all oral chronic medication intended for one dosing moment is packed in plastic disposable pouches. Controls received VKAs by manual dispensing. The difference in TTR between the 6 months after- and 6 months before the index date. A mixed-effects model with the intervention, TTR before the index date, MDD system at baseline as covariates, and pharmacy as random effect. A per-protocol analysis was performed with all patients who completed the study as intended. Results: One hundred and seventy-nine patients were included. Mean age was 80.0 (SD 6.9) years. Mean TTR during the study was 79.2 ± 18.0% in the intervention group and 72.5 ± 20.1% in the control group. The intervention resulted in a 5.6% (95% CI: 0.1-11.1) increase in TTR compared to the control group. Per-protocol analysis resulted in an 8.3% (95% CI: 0.99-15.61) increase in TTR compared to the control group. No differences in reduction were observed between the intervention and control group. Conclusion: The quality of anticoagulation can be improved with the use of MDD systems.
| Original language | English |
|---|---|
| Pages (from-to) | 70-78 |
| Journal | Journal of Thrombosis and Haemostasis |
| Volume | 18 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2020 |
Funding
B. Mertens received an unconditional grant for the PhD project about MDD to conduct this research. The other authors declare no conflict of interest. This study was performed as part of a larger PhD project on MDD. The project received unrestricted funding from The Royal Dutch Pharmacists Association and from a conjunction of MDD suppliers (SPITS BV, Apotheek Voorzorg BV, Verpakapotheek, Pluripack, 5 Sterrenapotheek, Brocacef Maatmedicatie BV) in the Netherlands. All intellectual and publication rights are reserved for the investigators. Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Keywords
- atrial fibrillation
- community pharmacy
- medication adherence
- multidose drug dispensing
- TTR